Bavarian Nordic A/S (BVNRY)
| Previous close | 16.37 |
| Open | 16.37 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 16.37 - 16.37 |
| 52-week range | 9.10 - 19.25 |
| Volume | 400 |
| Avg. volume | 255 |
| Market cap | 3.14B |
| Beta (5Y monthly) | 1.44 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.55 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 27 Mar 2020 |
| 1y target est | N/A |
- Globe Newswire
Bavarian Nordic’s COVID-19 Funding Agreement with the Danish Ministry of Health Receives Final Approval from Parliament
COPENHAGEN, Denmark, September 24, 2021 – Bavarian Nordic A/S (OMX: BAVA) announced today that the funding agreement recently entered with the Danish Ministry of Health to further advance the development of ABNCoV2, the Company’s COVID-19 vaccine candidate, has now been approved by the Finance Committee of the Danish Parliament, thereby finally executing the agreement. For detailed information about the agreement, see company announcement no. 27/2021. About Bavarian NordicBavarian Nordic is a fu
- Globe Newswire
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, September 16, 2021 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transaction of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such. The transaction concerns the exercise of warrants by Thomas Bennekov, who has served as an employee-elected member of the Board of Directors of Bavarian Nordic since April 2021. The warrants were awarded to Mr. Benneko
- Globe Newswire
Bavarian Nordic A/S - Articles of Association
Updated Articles of Association for Bavarian Nordic A/S. Attachment Bavarian Nordic - Articles of Association
